Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

This study is a pre-planned country-specific subanalysis of results in Germany from a multinational multicenter registry to prospectively assess real-world experience with caspofungin administered for treatment of proven or probable invasive aspergillosis (IA).

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Egerer, Gerlinde (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 April 2012
In: European journal of medical research
Year: 2012, Jahrgang: 17
ISSN:2047-783X
DOI:10.1186/2047-783X-17-7
Online-Zugang:Verlag, Volltext: https://doi.org/10.1186/2047-783X-17-7
Volltext
Verfasserangaben:Gerlinde Egerer, Dietmar Reichert, Mathias W. Pletz, Peter Kaskel, Karl J. Krobot and Johan Maertens
Beschreibung
Zusammenfassung:This study is a pre-planned country-specific subanalysis of results in Germany from a multinational multicenter registry to prospectively assess real-world experience with caspofungin administered for treatment of proven or probable invasive aspergillosis (IA).
Beschreibung:Gesehen am 18.06.2019
Beschreibung:Online Resource
ISSN:2047-783X
DOI:10.1186/2047-783X-17-7